BIOEMBRACE-1
Not Applicable
- Conditions
- Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified
- Registration Number
- CTRI/2019/03/018331
- Lead Sponsor
- Tata memorial Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1) The study population will include patients recruited in the EMBRACE and EMBRACE-II studies that have completed treatment and have baseline and follow up information available.
2) Tumour sample inclusion for the molecular study necessitates that at least >40% of the sample is composed of viable tumour cells.
Exclusion Criteria
Tumour samples with less than < 40% viable tumour cells will be excluded
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method